J Cell Mol Med. 2024 Aug;28(15):e18563. doi: 10.1111/jcmm.18563.
J. Cao, H. Wang, G. Liu, R. Tang, Y. Ding, P. Xu, H. Wang, J. Miao, X. Gu, and S. Han, 'LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via Mir-455-5p and Mir-491-5p sponging', Journal of Cellular and Molecular Medicine 25, no. 2 (2021): 1178-1189, https://doi.org/10.1111/jcmm.16185. The above article, published online on 20 December 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan Constantinescu; The Foundation for Cellular and Molecular Medicine; and John Wiley and Sons Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed inappropriate duplications of image panels (Figure 2C, D, E and 5C) between this and other articles that were either previously published or published later in the same year. Thus, the editors consider the conclusions of this manuscript substantially compromised. The authors were informed of the decision to retract but did not respond to the retraction decision or the wording.
曹杰、王浩、刘刚、唐锐、丁洋、徐鹏、王浩、苗佳、顾鑫、韩松，“LBX2-AS1 通过充当 Mir-455-5p 和 Mir-491-5p 的海绵促进 E2F2 基因表达从而推动卵巢癌进展”，《细胞与分子医学杂志》25 卷，第 2 期（2021 年）：1178 - 1189，https://doi.org/10.1111/jcmm.16185。上述文章于 2020 年 12 月 20 日在线发表于威利在线图书馆（wileyonlinelibrary.com），经该期刊主编斯特凡·康斯坦丁内斯库、细胞与分子医学基金会以及约翰·威利父子有限公司协商一致后予以撤稿。此次撤稿是在对第三方提出的担忧进行调查之后达成的，调查发现本文与同年之前发表或之后发表的其他文章之间存在图像板块（图 2C、D、E 和 5C）的不当重复。因此，编辑们认为该稿件的结论受到了实质性损害。已告知作者撤稿决定，但作者未对撤稿决定或措辞做出回应。
